慢性乙型肝炎:治疗所有感染病毒的人?
1Department of Medicine, New York University Grossman School of Medicine, 150 East 32nd Street, Suite 101, New York, NY 10016, USA; New York University Langone Transplant Institute, 317 East 34th Street, 8th Floor, New York, NY 10016, USA.
慢性乙型肝炎 (CHB) 的抗病毒治疗旨在预防疾病进展和肝癌. 扩大治疗资格可能会使更多的CHB患者受益,即使是那些不符合当前标准的患者.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 在瘤学瘤学.
背景情况:
- 慢性乙型肝炎 (CHB) 管理侧重于预防疾病进展和肝细胞癌 (HCC).
- 目前的指导方针建议针对特定高风险患者群体进行抗病毒治疗.
- 然而,不符合这些标准的患者仍然可能从治疗中受益.
研究的目的:
- 审查CHB的传统治疗模式.
- 为扩大抗病毒治疗资格超出目前的指导方针辩论.
- 考虑对不符合治疗标准的病毒病患者的好处.
主要方法:
- 审查关于CHB治疗指南的现有文献.
- 在更广泛的患者群体中分析抗病毒疗法的益处.
- 讨论高效抗病毒药物的影响.
主要成果:
- 抗病毒治疗可以减少CHB相关的并发症.
- 高效且耐受性良好的抗病毒药物随时可用.
- 越来越多地质疑向病毒性患者保留治疗.
结论:
- 扩大不符合当前标准的CHB患者的抗病毒治疗资格是有必要的.
- 更广泛的治疗可能会减少长期并发症并改善结果.
- 有效药物的可用性支持了更具包容性的治疗方法.
更多相关视频
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
相关概念视频
Myocarditis III: Medical Management
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Retrovirus Life Cycles
Chronic Pancreatitis II: Collaborative Care
Assessment:
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Viruses with RNA Genomes
